메뉴 건너뛰기




Volumn 22, Issue 1, 2012, Pages 658-665

The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors

Author keywords

Amide; Angiotensin; Angiotensinase C; Benzimidazole; Bioisostere; Enzyme inhibitor; Medicinal chemistry; Melanocyte stimulating hormone; Metabolic syndrome; Obesity; P glycoprotein; P gP; PrCP; Prekallikrein; Prolylcarboxypeptidase

Indexed keywords

AMIDE; BENZYLAMINE DERIVATIVE; GLYCOPROTEIN P; PEPTIDE HYDROLASE INHIBITOR; PROLINE CARBOXYPEPTIDASE; PROLYLCARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 84655162123     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.10.060     Document Type: Article
Times cited : (14)

References (39)
  • 22
    • 84655174396 scopus 로고    scopus 로고
    • Chissoe, S. U.S. Patent Application 20080108080A1.
    • Chissoe, S. U.S. Patent Application 20080108080A1.
  • 38
    • 84655174393 scopus 로고    scopus 로고
    • The mouse AngIII assay involved treating the whole mouse plasma with protease inhibitors to suppress the conversion of AngIII to Ang (2-7) by non-PrCP proteases. The PrCP inhibitor was then added to study the rate of conversion of AngIII to Ang (2-7) as compared to a vehicle treated control.
    • The mouse AngIII assay involved treating the whole mouse plasma with protease inhibitors to suppress the conversion of AngIII to Ang (2-7) by non-PrCP proteases. The PrCP inhibitor was then added to study the rate of conversion of AngIII to Ang (2-7) as compared to a vehicle treated control.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.